Clinical Trials Directory

Trials / Completed

CompletedNCT04263701

Dual Task Training in Spastic Cerebral Palsy

Effects of Dual Task Training on Gait Parameters in Spastic Diplegic Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Kutahya Health Sciences University · Academic / Other
Sex
All
Age
7 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the effects of dual task training on gait and balance parameters, gross motor function skills, functional mobility skills, functional independence levels and health-related quality of life o in children with spastic diplegic cerebral palsy. The clinical study's hypothesis is the dual task training programs are superior to conventional physiotherapy programs to improve the parameters in spastic diplegic cerebral palsy.

Detailed description

In this self-controlled study, children with spastic diplegic cerebral palsy, aged 7-16, who were at level 1 or 2 according to the Gross Motor Function Classification System, scored 27 and above from the Modified Mini Mental Test were included. Children are recruited to the routine physiotherapy program 45 minutes 2 days a week for 8 weeks, and in addition to the routine physiotherapy program dual task training program 45 minutes 2 days a week for the next 8 weeks. The children will evaluate at baseline, after the routine physiotherapy program and after the dual task training program. Children will be evaluate with Gross Motor Function Measurement-88,Modified Ashworth Scale , gait platform, Edinburgh Visual Gait Score, Pediatric Berg Balance Scale,1 Minute Walk Test, Functional Independence Measure, Pediatric Quality of Life Inventory TM-Cerebral Palsy Module.

Conditions

Interventions

TypeNameDescription
OTHERTherapeutic exercisesConventional physiotherapy exercises for children with cerebral palsy
OTHERDual Task TrainingDual task training in addition to conventional physiotherapy exercises for children with cerebral palsy

Timeline

Start date
2019-07-01
Primary completion
2020-03-15
Completion
2020-03-15
First posted
2020-02-11
Last updated
2021-03-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04263701. Inclusion in this directory is not an endorsement.